Reply letter to “safety of SARS-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance”

ABSTRACT

In the letter, Urro et al. performed a search on the sucrose, fructose and sorbitol content in the approved Sars-Cov-2 vaccines and they concluded that these vaccines can be safely administered in adults affected by Hereditary fructose intolerance.

The Pfizer-BioNTech COVID-19 Vaccine is currently approved for use in adolescents ≥ 12 years and the Moderna COVID-19 vaccine is close to approval for use in children over 12 years of age. Furthermore, both vaccines have initiated clinical trials that will include infant as young as 6 months. Therefore, we considerate important to analyze the safely administration of this two vaccines in children with Hereditary fructose intolerance.

KEYWORDS:

• SARS-Cov 2; vaccine; Hereditary fructose intolerance; children; sucrose

Disclosure of potential conflicts of interest

The authors report no conflict of interest.